Olema Oncology

About:

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

Website: https://olema.com

Twitter/X: olemapharma

Top Investors: BlackRock, Lightspeed Venture Partners, Deerfield, Silicon Valley Bank, OrbiMed

Description:

Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company focuses on the discovery, development, and commercialization of targeted therapies for women's cancers. It leverages the knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development. Olema leverages their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance with the goal of transforming the standard of care for pre- and post-menopausal women living with cancer by developing more convenient and effective therapies.